Are you going to CPHI Frankfurt? We are! Stop by booth 5.1A63 and let's talk about what we can do to help move your product forward! From R&D to cGMP Manufacturing - We meet all your small molecule API development needs. We've 20+ years of experience in cGMP Manufacturing at our US based Delaware site. Better Science, Faster! #CPHI #CPHIFrankfurt
Wilmington PharmaTech Company LLC
Pharmaceutical Manufacturing
Newark, DE 692 followers
Better Science for Better Results
About us
Wilmington PharmaTech Company LLC is a leading global service company specializing in the research and development of chemical process and medicinal chemistry for the pharmaceutical and biotechnology industries. Founded in 2003, WPT has a track record of reliable and quality services for pharma and biotech companies worldwide with the state of art facilities and operations in the United States and China. Based on the established expertise and proprietary technologies, WPT has developed a wide range of capabilities for the research and development of today’s medicines, including custom synthesis, process chemistry, medicinal chemistry, API manufacturing, FTE research, polymorph screening and salt selection, and analytical services.
- Website
-
http://www.wilmingtonpharmatech.com
External link for Wilmington PharmaTech Company LLC
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Newark, DE
- Type
- Privately Held
- Specialties
- cGMP Synthesis, FTE Contract Research, Polymorph Screening and Salt Selection, Analytical GLP and GMP Services, Genotoxic Impurity Trace Analysis, Stable Isotope Labeling, Drug Reference Standards, Biotransformation, Chiral Resolution, and Asymmetric Catalysis
Locations
-
Primary
Get directions
229A Lake Drive
Newark, DE 19702, US
Employees at Wilmington PharmaTech Company LLC
-
Carl Behrens
VP of Chemistry and Business Development
-
Hongfeng Chen
Executive Vice President and General Manager for Manufacturing at Wilmington PharmaTech Company LLC
-
Hui-Yin Harry Li
President and CEO at Wilmington PharmaTech
-
Russell A. Craig III
Production Manager at Wilmington PharmaTech
Updates
-
𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝗔𝗣𝗜 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦𝗔 𝗶𝘀 𝗮 𝗵𝗼𝘁 𝘁𝗼𝗽𝗶𝗰! Check out our CEO, Hui-Yin Harry Li, present at the #CPHI Preview telecast on how we deliver comprehensive support for pharma innovators. See us at booth 5.1A63. From lead identification to clinical development to cGMP manufacturing of starting materials and full APIs, including highly potent materials, full analytical support and complete CMC solutions... Watch the video below 👇 Schedule a meeting at CPHI Frankfurt: https://lnkd.in/ezTcYF4c #CPHI #CPHIFrankfurt #Pharma
-
Check out a great story from Fierce on our investment partnership with Curewell Capital featuring our CEO Harry Li and Curewell Capital Managing Partner Michael Dal Bello! https://lnkd.in/em9AW8kA
-
Big news! WPT partners with Curewell Capital! Check out the PR: https://lnkd.in/eum7_BYV
-
-
Your trusted partner - Same Location, Same Booth Number, Every Year!
We will be attending #ChemOutsourcing from September 2-5 in Parsippany, NJ. Come visit us at Booth 70!
-